Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 20,191Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Dasami Lab Private Limited

02 1MSD International GmbH

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

BioAsia
Not Confirmed
arrow
arrow
BioAsia
Not Confirmed

SUVOREXANT

NDC Package Code : 70966-0034

Start Marketing Date : 2014-08-13

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

02

BioAsia
Not Confirmed
arrow
arrow
BioAsia
Not Confirmed

SUVOREXANT

NDC Package Code : 50473-0029

Start Marketing Date : 2012-12-01

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

Looking for 1030377-33-3 / Suvorexant API manufacturers, exporters & distributors?

Suvorexant manufacturers, exporters & distributors 1

21

PharmaCompass offers a list of Suvorexant API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Suvorexant manufacturer or Suvorexant supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Suvorexant manufacturer or Suvorexant supplier.

PharmaCompass also assists you with knowing the Suvorexant API Price utilized in the formulation of products. Suvorexant API Price is not always fixed or binding as the Suvorexant Price is obtained through a variety of data sources. The Suvorexant Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Suvorexant

Synonyms

1030377-33-3, Mk-4305, Belsomra, Mk4305, Mk 4305, [(7r)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2h-1,2,3-triazol-2-yl)phenyl]methanone

Cas Number

1030377-33-3

Unique Ingredient Identifier (UNII)

081L192FO9

About Suvorexant

Suvorexant is a selective dual antagonist of orexin receptors OX1R and OX2R that promotes sleep by reducing wakefulness and arousal. It has been approved for the treatment of insomnia.

Suvorexant Manufacturers

A Suvorexant manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Suvorexant, including repackagers and relabelers. The FDA regulates Suvorexant manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Suvorexant API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Suvorexant manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Suvorexant Suppliers

A Suvorexant supplier is an individual or a company that provides Suvorexant active pharmaceutical ingredient (API) or Suvorexant finished formulations upon request. The Suvorexant suppliers may include Suvorexant API manufacturers, exporters, distributors and traders.

click here to find a list of Suvorexant suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Suvorexant NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Suvorexant as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Suvorexant API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Suvorexant as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Suvorexant and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Suvorexant NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Suvorexant suppliers with NDC on PharmaCompass.

Suvorexant Manufacturers | Traders | Suppliers

Suvorexant Manufacturers, Traders, Suppliers 1
28

We have 2 companies offering Suvorexant

Get in contact with the supplier of your choice:

  1. Dasami Lab
  2. Merck & Co
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.